Sensors and Actuators B Chemical, Journal Year: 2025, Volume and Issue: unknown, P. 137959 - 137959
Published: May 1, 2025
Language: Английский
Sensors and Actuators B Chemical, Journal Year: 2025, Volume and Issue: unknown, P. 137959 - 137959
Published: May 1, 2025
Language: Английский
JACS Au, Journal Year: 2025, Volume and Issue: 5(3), P. 1402 - 1412
Published: Feb. 24, 2025
Oligonucleotide-based therapies, especially ligand-conjugated siRNAs, offer significant therapeutic potential for a wide array of diseases. However, conventional solid-phase synthesis and current postsynthetic in-solution conjugation methods face notable challenges related to efficiency, accessibility, the scalability diverse ligand–oligonucleotide conjugates. Herein, we introduce novel strategy highly efficient, rapid, modular assembly GalNAc–siRNA conjugates based on light-induced primary amine o-nitrobenzyl alcohol cyclization (PANAC) chemistry. Leveraging advantages PANAC photoclick chemistry linkers, our method enables direct trivalent GalNAc (tGalNAc) with commercially available primary-amine-modified siRNAs. This approach demonstrates efficient rapid therapeutically relevant oligonucleotides ligands interest, offering operational simplicity practicality; thus, it effectively overcomes limitations existing methods. More importantly, developed siRNA–tGalNAc showed robust gene silencing effect superior parent siRNA conjugate, highlighting effectiveness in generating screening enhance vivo potency. Overall, oligonucleotide–tGalNAc using readily accessible tGalNAc-amine ligands. expands toolkit conjugates, providing general platform broad applicability, thereby advancing optimization development oligonucleotide-based therapeutics.
Language: Английский
Citations
0Sensors and Actuators B Chemical, Journal Year: 2025, Volume and Issue: unknown, P. 137959 - 137959
Published: May 1, 2025
Language: Английский
Citations
0